Cargando…

Under-Treatment of Older Patients with Newly Diagnosed Epithelial Ovarian Cancer Remains an Issue

SIMPLE SUMMARY: Cancer treatment and survival in older women is topical and important in an era where the proportion of older adults being treated for cancer in the clinic is rising. As survival outcomes in older women continue to lag behind those of younger and middle-aged women, further investigat...

Descripción completa

Detalles Bibliográficos
Autores principales: Dumas, Lucy, Bowen, Rebecca, Butler, John, Banerjee, Susana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956315/
https://www.ncbi.nlm.nih.gov/pubmed/33668809
http://dx.doi.org/10.3390/cancers13050952
_version_ 1783664406698131456
author Dumas, Lucy
Bowen, Rebecca
Butler, John
Banerjee, Susana
author_facet Dumas, Lucy
Bowen, Rebecca
Butler, John
Banerjee, Susana
author_sort Dumas, Lucy
collection PubMed
description SIMPLE SUMMARY: Cancer treatment and survival in older women is topical and important in an era where the proportion of older adults being treated for cancer in the clinic is rising. As survival outcomes in older women continue to lag behind those of younger and middle-aged women, further investigation is required into current treatment practices to identify target areas to address this deficit. We present treatment patterns, tolerance and outcomes of 280 women aged 65 and above treated for newly diagnosed ovarian cancer at two UK cancer centres between 2009 and 2015. We demonstrate that older women continue to receive lower rates of standard care first line therapy. When adjusted for stage at diagnosis, surgical outcome and chemotherapy given, age was not an independent risk factor for poorer overall survival. ABSTRACT: Older women with ovarian cancer have disproportionately poorer survival outcomes than their younger counterparts and receive less treatment. In order to understand where the gaps lie in the treatment of older patients, studies incorporating more detailed assessment of baseline characteristics and treatment delivery beyond the scope of most cancer registries are required. We aimed to assess the proportion of women over the age of 65 who are offered and receive standard of care for first-line ovarian cancer at two UK NHS Cancer Centres over a 5-year period (December 2009 to August 2015). Standard of care treatment was defined as a combination of cytoreductive surgery and if indicated platinum-based chemotherapy (combination or single-agent). Sixty-five percent of patients aged 65 and above received standard of care treatment. Increasing age was associated with lower rates of receiving standard of care (35% > 80 years old versus 78% of 65–69-year-olds, p = 0.000). Older women were less likely to complete the planned chemotherapy course (p = 0.034). The oldest women continue to receive lower rates of standard care compared to younger women. Once adjusted for Federation of Gynaecology and Obstetrics (FIGO) stage, Eastern Cooperative Oncology Group (ECOG) performance status and first-line treatment received, age was no longer an independent risk factor for poorer overall survival. Optimisation of vulnerable patients utilising a comprehensive geriatric assessment and directed interventions to facilitate the delivery of standard of care treatment could help narrow the survival discrepancy between the oldest patients and their younger counterparts.
format Online
Article
Text
id pubmed-7956315
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-79563152021-03-15 Under-Treatment of Older Patients with Newly Diagnosed Epithelial Ovarian Cancer Remains an Issue Dumas, Lucy Bowen, Rebecca Butler, John Banerjee, Susana Cancers (Basel) Article SIMPLE SUMMARY: Cancer treatment and survival in older women is topical and important in an era where the proportion of older adults being treated for cancer in the clinic is rising. As survival outcomes in older women continue to lag behind those of younger and middle-aged women, further investigation is required into current treatment practices to identify target areas to address this deficit. We present treatment patterns, tolerance and outcomes of 280 women aged 65 and above treated for newly diagnosed ovarian cancer at two UK cancer centres between 2009 and 2015. We demonstrate that older women continue to receive lower rates of standard care first line therapy. When adjusted for stage at diagnosis, surgical outcome and chemotherapy given, age was not an independent risk factor for poorer overall survival. ABSTRACT: Older women with ovarian cancer have disproportionately poorer survival outcomes than their younger counterparts and receive less treatment. In order to understand where the gaps lie in the treatment of older patients, studies incorporating more detailed assessment of baseline characteristics and treatment delivery beyond the scope of most cancer registries are required. We aimed to assess the proportion of women over the age of 65 who are offered and receive standard of care for first-line ovarian cancer at two UK NHS Cancer Centres over a 5-year period (December 2009 to August 2015). Standard of care treatment was defined as a combination of cytoreductive surgery and if indicated platinum-based chemotherapy (combination or single-agent). Sixty-five percent of patients aged 65 and above received standard of care treatment. Increasing age was associated with lower rates of receiving standard of care (35% > 80 years old versus 78% of 65–69-year-olds, p = 0.000). Older women were less likely to complete the planned chemotherapy course (p = 0.034). The oldest women continue to receive lower rates of standard care compared to younger women. Once adjusted for Federation of Gynaecology and Obstetrics (FIGO) stage, Eastern Cooperative Oncology Group (ECOG) performance status and first-line treatment received, age was no longer an independent risk factor for poorer overall survival. Optimisation of vulnerable patients utilising a comprehensive geriatric assessment and directed interventions to facilitate the delivery of standard of care treatment could help narrow the survival discrepancy between the oldest patients and their younger counterparts. MDPI 2021-02-25 /pmc/articles/PMC7956315/ /pubmed/33668809 http://dx.doi.org/10.3390/cancers13050952 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Dumas, Lucy
Bowen, Rebecca
Butler, John
Banerjee, Susana
Under-Treatment of Older Patients with Newly Diagnosed Epithelial Ovarian Cancer Remains an Issue
title Under-Treatment of Older Patients with Newly Diagnosed Epithelial Ovarian Cancer Remains an Issue
title_full Under-Treatment of Older Patients with Newly Diagnosed Epithelial Ovarian Cancer Remains an Issue
title_fullStr Under-Treatment of Older Patients with Newly Diagnosed Epithelial Ovarian Cancer Remains an Issue
title_full_unstemmed Under-Treatment of Older Patients with Newly Diagnosed Epithelial Ovarian Cancer Remains an Issue
title_short Under-Treatment of Older Patients with Newly Diagnosed Epithelial Ovarian Cancer Remains an Issue
title_sort under-treatment of older patients with newly diagnosed epithelial ovarian cancer remains an issue
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956315/
https://www.ncbi.nlm.nih.gov/pubmed/33668809
http://dx.doi.org/10.3390/cancers13050952
work_keys_str_mv AT dumaslucy undertreatmentofolderpatientswithnewlydiagnosedepithelialovariancancerremainsanissue
AT bowenrebecca undertreatmentofolderpatientswithnewlydiagnosedepithelialovariancancerremainsanissue
AT butlerjohn undertreatmentofolderpatientswithnewlydiagnosedepithelialovariancancerremainsanissue
AT banerjeesusana undertreatmentofolderpatientswithnewlydiagnosedepithelialovariancancerremainsanissue